AR040690A1 - Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar o prevenir la insuficiencia cardiaca - Google Patents

Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar o prevenir la insuficiencia cardiaca

Info

Publication number
AR040690A1
AR040690A1 AR20030102678A ARP030102678A AR040690A1 AR 040690 A1 AR040690 A1 AR 040690A1 AR 20030102678 A AR20030102678 A AR 20030102678A AR P030102678 A ARP030102678 A AR P030102678A AR 040690 A1 AR040690 A1 AR 040690A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically acceptable
acceptable salts
amine derivative
cyclic amine
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AR20030102678A
Other languages
English (en)
Inventor
Guth Brian Dt
Seidler Randolph Dr
Daemmgen Juergen Dr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29265956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR040690(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR040690A1 publication Critical patent/AR040690A1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de una composición farmacéutica de un derivado de amina cíclica específico, o sus sales farmacéuticamente aceptables, pata tratar o prevenir la insuficiencia cardiaca de cualquier etiología. Reivindicación 1: Uso de cilobradina o una de sus sales farmacéuticamente aceptable, para preparar una composición farmacéutica para tratar o prevenir la insuficiencia cardiaca.
AR20030102678A 2002-07-25 2003-07-25 Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar o prevenir la insuficiencia cardiaca Pending AR040690A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02016602A EP1362590B1 (en) 2002-07-25 2002-07-25 Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Publications (1)

Publication Number Publication Date
AR040690A1 true AR040690A1 (es) 2005-04-13

Family

ID=29265956

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030102678A Pending AR040690A1 (es) 2002-07-25 2003-07-25 Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar o prevenir la insuficiencia cardiaca

Country Status (29)

Country Link
US (1) US20130317008A1 (es)
EP (2) EP1362590B1 (es)
JP (3) JP2005533853A (es)
KR (1) KR20050074432A (es)
CN (1) CN100502874C (es)
AR (1) AR040690A1 (es)
AT (2) ATE257384T1 (es)
AU (1) AU2003254554B8 (es)
BR (1) BR0312852A (es)
CA (1) CA2493208C (es)
CO (1) CO5700723A2 (es)
CY (1) CY1112173T1 (es)
DE (1) DE60200160T2 (es)
DK (2) DK1362590T3 (es)
ES (2) ES2211846T3 (es)
HR (1) HRP20050075B1 (es)
MX (1) MXPA05000617A (es)
MY (1) MY128529A (es)
NZ (1) NZ538424A (es)
PE (1) PE20040706A1 (es)
PL (1) PL214716B1 (es)
PT (2) PT1362590E (es)
SA (1) SA03240350B1 (es)
SI (2) SI1362590T1 (es)
TR (1) TR200400127T4 (es)
TW (1) TWI319321B (es)
UY (1) UY27910A1 (es)
WO (1) WO2004011006A1 (es)
ZA (1) ZA200500084B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1362590E (pt) * 2002-07-25 2004-05-31 Boehringer Ingelheim Pharma Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
US20040138306A1 (en) 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
WO2007023775A1 (ja) * 2005-08-23 2007-03-01 Astellas Pharma Inc. 心房細動治療剤
EP1762179A1 (en) 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2927538B1 (fr) 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013024023A1 (en) * 2011-08-12 2013-02-21 Boehringer Ingelheim Vetmedica Gmbh Taste masked pharmaceutical composition
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541811A1 (de) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
JP4240173B2 (ja) * 1998-06-03 2009-03-18 日産化学工業株式会社 インダン誘導体
PT1186601E (pt) * 1999-06-03 2004-06-30 Yamanouchi Pharma Co Ltd Novos derivados de isoquinolina ou seus sais
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
PT1362590E (pt) * 2002-07-25 2004-05-31 Boehringer Ingelheim Pharma Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca

Also Published As

Publication number Publication date
EP1362590A1 (en) 2003-11-19
AU2003254554B8 (en) 2009-02-26
TR200400127T4 (tr) 2004-02-23
ES2367109T3 (es) 2011-10-28
UY27910A1 (es) 2004-02-27
EP1362590A8 (en) 2004-02-25
TW200412974A (en) 2004-08-01
ES2211846T3 (es) 2004-07-16
BR0312852A (pt) 2005-04-19
WO2004011006A1 (en) 2004-02-05
SI1534296T1 (sl) 2011-09-30
JP2005533853A (ja) 2005-11-10
ATE510543T1 (de) 2011-06-15
SA03240350B1 (ar) 2007-10-29
JP2013166781A (ja) 2013-08-29
HRP20050075A2 (en) 2005-12-31
KR20050074432A (ko) 2005-07-18
EP1534296A1 (en) 2005-06-01
DK1362590T3 (da) 2004-03-29
ATE257384T1 (de) 2004-01-15
JP2009256379A (ja) 2009-11-05
DE60200160D1 (de) 2004-02-12
ZA200500084B (en) 2005-10-26
CO5700723A2 (es) 2006-11-30
EP1362590B1 (en) 2004-01-07
EP1534296B1 (en) 2011-05-25
NZ538424A (en) 2006-10-27
PL372993A1 (en) 2005-08-08
MXPA05000617A (es) 2005-08-19
CN1671392A (zh) 2005-09-21
CA2493208C (en) 2011-11-01
DE60200160T2 (de) 2004-11-04
CA2493208A1 (en) 2004-02-05
PT1534296E (pt) 2011-08-18
DK1534296T3 (da) 2011-08-15
PT1362590E (pt) 2004-05-31
PL214716B1 (pl) 2013-09-30
US20130317008A1 (en) 2013-11-28
SI1362590T1 (en) 2004-04-30
MY128529A (en) 2007-02-28
HRP20050075B1 (hr) 2013-12-20
AU2003254554B2 (en) 2009-01-29
CN100502874C (zh) 2009-06-24
PE20040706A1 (es) 2004-12-06
AU2003254554A1 (en) 2004-02-16
CY1112173T1 (el) 2015-12-09
TWI319321B (en) 2010-01-11

Similar Documents

Publication Publication Date Title
BR0315337A (pt) Composto, formulação farmacêutica, e, método para tratar câncer
NO20074295L (no) Substituerte gamma lactamer som terapeutiske midler
BR0315959A (pt) Composto, composição farmacêutica uso do composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso e processo para a preparação do composto
BR0109703A (pt) Derivados de piperazina
CR6616A (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas
BRPI0512193B8 (pt) composto ou sal farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou sal
UY27965A1 (es) Derivados heterocíclicos
AR048588A1 (es) Uso de inhibidores de la fosfodiesterasa de tipo iii (pde iii) para la reduccion del tamano del corazon en mamiferos que padecen insuficiencia cardiaca
NO20060871L (no) Azepinderivater som farmasoytiske midler
NO20051966L (no) Nye pyrimidinamidderivater og anvendelse derav
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
CY1110289T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια ρινιτιδων
CY1112173T1 (el) Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας
AR039633A2 (es) Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
DK1791537T3 (da) 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase
CY1105591T1 (el) Αναστολεις για συνθαση του 20-ηετε
BR0013582A (pt) Agonistas retinóides seletivos para rar
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
UY27324A1 (es) Nuevas sales de napsilato i
CO5021190A1 (es) Agentes terapeuticos
PT1183046E (pt) Derivado de aminotetralina para a terapia de doencas cardiovasculares

Legal Events

Date Code Title Description
FA Abandonment or withdrawal